NEMUCORE MEDICAL INNOVATIONS, INC.
Biotech · Private
Recombinant human Müllerian Inhibiting Substance (rhMIS) protein therapeutic for ovarian cancer
nemucore.com →- Grants
- $225K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 14
- 0 granted · 14 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142015
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Modified MIS Production & Process Development for Preclinical & Clinical Studies | $225,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1691 | iQure Pharma Inc. | — | $5.3M |
| 1692 | MicroMGx, Inc. | — | — |
| 1693 | AEON RESPIRE, INC. | — | — |
| 1694 | NEMUCORE MEDICAL INNOVATIONS, INC. | — | — |
| 1695 | Epigen Biosciences, Inc. | — | — |
| 1696 | ONECYTE BIOTECHNOLOGIES, INC. | — | — |
| 1697 | Igenica | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Degradation Of Aurora Kinase (aurk) By Conjugation Of Aurk Inhibitors With E3 Ligase Ligandapplication
- Platinum Derivatives For Hydrophobic Formulationsapplication
- Nanoemulsions Of Hydrophobic Platinum Derivativesapplication
- Therapeutic Nanoemulsion Formulation For The Targeted Delivery Of Docetaxel And Methods Of Making And Using The Sameapplication
- Image Guided Nanoemulsions For Delivering Therapeutic Agents To The Brain And Methods For Their Preparation And Useapplication
- Drug Delivery Nanoemulsion Systemsapplication
- Therapeutic Nanoformulations For Delivery To And Imaging Of The Brain And Methods Of Their Preparation And Use (II)application
- Nanoemulsion Formulations Of Hydrophobic Platinum Derivatives And Methods Of Their Preparation And Useapplication
- Drug Delivery System Nanoemulsion Formulationsapplication
- Platinum Derivatives For Hydrophobic Formulations And Preparation And Uses Thereofapplication
- Multifunctional Nanoemulsions For Therapyapplication
- Degradation Of Aurora Kinase (aurk) By Conjugation Of Aurk Inhibitors With E3 Ligase Ligandapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.